Artículos científicos Open Access
Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
The Lancet Infectious Diseases
Maryam Nazemipour, Maryam ShakibaMohammad, Ali Mansournia
Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply
The Lancet Infectious Diseases
Maryam Darvishian, et al
Patient factors and temporal trends associated with COVID-19 in-hospital mortality in England: an observational study using administrative data
The Lancet Respiratory Medicine
Annakan V Navaratnam, et al
Trends in COVID-19-related in-hospital mortality: lessons learned from nationwide samples
The Lancet Respiratory Medicine
Purnema Madahar, et al
Clinical outcomes of different therapeutic options for COVID-19 in two Chinese case cohorts: A propensity-score analysis
EClinicalMedicine
Carlos K.H. Wong, et al
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
The Lancet
Olivier J Wouters, et al
Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission
The Lancet
Commissioners of the Lancet COVID-19 Commission Task Force Chairs and members of the Lancet COVID-19 Commission Commission Secretariat and Staff of the Lancet COVID-19 Commission
Genomic-informed pathogen surveillance in Africa: opportunities and challenges
The Lancet
Seth C Inzaule, et al
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
NEJM
Danuta M. Skowronski, M.D., Gaston De Serres, M.D., Ph.D.
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine — Preliminary Report
NEJM
Kai Wu, Ph.D., et al
Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination
NEJM
Siri R. Kadire, M.D., Robert M. Wachter, M.D., and Nicole Lurie, M.D., M.S.P.H.
